Efficacy of follow-up after surgical treatment of colorectal liver metastases

European Journal of Surgical Oncology

Volumn 35, Issue 2, 2009, Pages 180-186

  Langenhoff, B S ^a   Krabbe, P F M ^a   Ruers, T J M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Colorectal cancer; Follow up; Metastases

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; POSTOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 58149512745     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.06.189     Document Type: Article

References (15)

1. Adson M.A., Ilstrup D.M., Fortner J.C., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100 (1986) 278-284
2. Khatri V.P., Petrelli N.J., and Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol 23 (2005) 8490-8499
3. Ellis V., Pollock R., Broglio K.R., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 816-825
4. Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
5. Vezeridis M.P. Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery 119 (1996) 361-371
6. Sugarbaker P.H. Repeat hepatectomy for colorectal metastases. J Hepatobiliary Pancreat Surg 6 (1999) 30-38
7. Metcalfe M.S., Mullin E.J., and Maddern G.J. Choice of surveillance after hepatectomy for colorectal metastases. Arch Surg 139 (2004) 749-754
8. Valeanu A., Castaing D., Azoulay D., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
9. Fuchs C.S., Ramanathan R.K., Williamson S.K., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22 (2004) 23-30
10. Balladur P., Boudjema K., Bachellier P., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77 (1996) 1254-1262
11. O'Dwyer S.T. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 324 (2002) 813
12. Ireland H., Madhaven K.K., Parks R.W., et al. Follow-up and outcomes for resection of colorectal liver metastases in Edinburgh. Eur J Surg Oncol 33 (2007) 55-60
13. Cartwright T., Hainsworth J., Heim W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
14. Brunet R., Butts C., Conroy T., et al. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol 22 (2004) 2084-2091
15. Kelly H., and Goldberg R.M. Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 23 (2005) 4553-4560